Addex Therapeutics (ADXN) vs Pulmatrix (PULM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Addex Therapeutics is the larger company by market cap ($5.6 million vs $5.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ADXN | PULM |
|---|---|---|
| Share price | $3.22 | $1.46 |
| Market cap | $5.64M | $5.33M |
| 1-day change | +1.21% | -4.39% |
| EPS (TTM) | $-7.56 | $-1.10 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $11.97 | $5.24 |
| 52-week low | $2.56 | $1.16 |
| Distance from 52-week high | -73.11% | -72.11% |
| Average volume | 138.20K | 24.09K |
| Shares outstanding | 1.75M | 3.65M |
| Employees | 3 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Addex Therapeutics
ADXN stock →Addex Therapeutics Ltd discovers, develops, and commercializes small-molecule pharmaceutical products for neurological disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors and enzymes.
Health Care · Biotechnology: Pharmaceutical Preparations · 3 employees
About Pulmatrix
PULM stock →Pulmatrix, Inc., a biopharmaceutical company, focused on development of novel inhaled therapeutic products to prevent and treat migraine and respiratory diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
ADXN vs PULM FAQ
Which is bigger, Addex Therapeutics or Pulmatrix?
Addex Therapeutics (ADXN) is larger, with a market capitalization of $5.64M compared with $5.33M for Pulmatrix (PULM).
Are Addex Therapeutics and Pulmatrix in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.